🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03327779
Recruiting Observational

World Bleeding Disorders Registry

NCT03327779 · tracked via the Priya Life Science Canada tracker
Sponsor
World Federation of Hemophilia
Phase
Observational
Started
2018-01-26
Last updated
2023-08-14

Condition(s) studied

Hemophilia AHemophilia BVon Willebrand Diseases

Study summary

The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to collect uniform and standardized patient data and guide clinical practice. With informed consent from the patient, the WBDR stores anonymous data about the person's disease, such as hemophilia type and severity, symptoms, and treatment.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients of participating Hemophilia Treatment Centres with Hemophilia A or B, or von Willebrand Disease Exclusion Criteria: * none

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
World Federation of Hemophilia Montreal Quebec Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03327779 on ClinicalTrials.gov ↗ ← All trials in Canada